Fahrni Guillaume, Saliba Thomas, Racine Damien, Gulizia Marianna, Tzimas Georgios, Pozzessere Chiara, Rotzinger David C
Department of Diagnostic and Interventional Radiology, Lausanne University Hospital, University of Lausanne, Rue du Bugnon 46, 1011 Lausanne, Switzerland.
Institute of Radiation Physics, Lausanne University Hospital, University of Lausanne, Rue du Grand-Pré 1 46, 1007 Lausanne, Switzerland.
J Cardiovasc Dev Dis. 2025 May 20;12(5):195. doi: 10.3390/jcdd12050195.
Coronary CT angiography (CCTA) has seen steady progress since its inception, becoming a key player in the non-invasive assessment of coronary artery disease (CAD). Advancements in CT technology, including iterative and deep-learning-based reconstruction, wide-area detectors, and dual-source systems, have helped mitigate early limitations, such as high radiation doses, motion artifacts, high iodine load, and non-diagnostic image quality. However, the adjustments between ionizing radiation and iodinated contrast material (CM) volumes remain a critical concern, especially due to the increasing use of CCTA in various indications. This review explores the balance between radiation and CM volumes, emphasizing patient-specific protocol optimization to improve diagnostic accuracy while minimizing risks. Radiation dose reduction strategies, such as low tube voltage protocols, prospective ECG-gating, and modern reconstruction algorithms, have significantly decreased radiation exposure, with some studies achieving sub-millisievert doses. Similarly, CM volume optimization, including adjustments in strategies for calculating CM volume, iodine concentration, and flow protocols, plays a role in managing risks such as contrast-associated acute kidney injury, particularly in patients with renal impairment. Emerging technologies, such as photon-counting CT and deep-learning reconstruction, promise further improvements in dose efficiency and image quality. This review summarizes current evidence, highlights the benefits and limitations of dose control approaches, and provides practical recommendations for practitioners. By tailoring protocols to patient characteristics, such as age, renal function, and body habitus, clinicians can achieve an optimal trade-off between diagnostic accuracy and patient safety, ensuring optimal operation of CT systems in clinical practice.
冠状动脉CT血管造影(CCTA)自问世以来取得了稳步进展,已成为冠状动脉疾病(CAD)无创评估的关键手段。CT技术的进步,包括基于迭代和深度学习的重建、大面积探测器和双源系统,有助于减轻早期的局限性,如高辐射剂量、运动伪影、高碘负荷和非诊断性图像质量。然而,电离辐射与碘化对比剂(CM)用量之间的调整仍然是一个关键问题,尤其是由于CCTA在各种适应症中的使用日益增加。本综述探讨了辐射与CM用量之间的平衡,强调针对患者的方案优化,以提高诊断准确性,同时将风险降至最低。辐射剂量降低策略,如低管电压方案、前瞻性心电图门控和现代重建算法,已显著降低了辐射暴露,一些研究实现了亚毫西弗剂量。同样,CM用量优化,包括计算CM用量、碘浓度和注射方案的策略调整,在管理诸如对比剂相关急性肾损伤等风险方面发挥作用,特别是在肾功能受损的患者中。光子计数CT和深度学习重建等新兴技术有望进一步提高剂量效率和图像质量。本综述总结了当前证据,强调了剂量控制方法的益处和局限性,并为从业者提供了实用建议。通过根据患者特征(如年龄、肾功能和体型)调整方案,临床医生可以在诊断准确性和患者安全之间实现最佳平衡,确保CT系统在临床实践中的最佳运行。